Shearman & Sterling advised underwriters Morgan Stanley, J.P. Morgan, BofA Merrill Lynch, Goldman, Sachs & Co., Jefferies, Deutsche Bank Securities, Blackstone Capital Markets, Piper Jaffray, Raymond James, Wells Fargo Securities, William Blair and Evercore in connection with the initial public offering of 42,500,000 shares of common stock of Catalent, Inc. The offering raised $871,250,000 and the shares have been listed on the New York Stock Exchange.

Catalent, Inc. is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products.

The Team